The rise of Sildenafil initially sparked a boom for major pharmaceutical companies, however recent developments present a complicated outlook for those considering a stake. Generic versions are eating into profits, and https://honeyqmri137805.ltfblog.com/39647651/sildenafil-and-big-pharma-a-risky-play